Argent BioPharma Limited (ASX:RGT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0810
-0.0040 (-4.71%)
At close: Jun 18, 2025, 4:00 PM AEST

Argent BioPharma Market Cap

Argent BioPharma has a market cap or net worth of 5.85 million as of June 18, 2025. Its market cap has decreased by -66.02% in one year.

Market Cap
5.85M
Enterprise Value
14.48M
Revenue
295.83K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y19 Jun 202018 Jun 20255Y ▾Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25050M100M150M200M250M6M

Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 5.85M, an increase of 87.55%. That is a compound annual growth rate of 5.06%.

History

DateMarket Cap% Change
Jun 18, 20255.85M-36.63%
Dec 31, 20249.23M-46.77%
Dec 29, 202317.33M-45.96%
Dec 30, 202232.07M-67.88%
Dec 31, 202199.85M123.36%
Dec 31, 202044.70M1.89%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 115.78B
Pro Medicus 28.66B
Cochlear 18.72B
Sonic Healthcare 12.87B
Telix Pharmaceuticals 8.66B
Ramsay Health Care 8.41B
Ansell 4.43B
Mesoblast 2.38B
Market Cap Rankings